Close Menu

NEW YORK (GenomeWeb) - Chembio Diagnostic Systems announced today that it has received a $550,000 grant from the Paul G. Allen Family Foundation to develop point-of-care diagnostics for the Zika virus.

Medford, New York-based Chembio will use the grant to develop a Zika-specific assay for  its Dual Path Platform (DPP) technology, as well as a multiplex assay to detect the Zika, Dengue, and Chikungunya viruses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.